StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Paromomycinsulfate

Paromomycin Sulfate

HCID 441375
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
1263-89-4
Standard-SMILES
NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O
InChIKey
LJRDOKAZOAKLDU-UDXJMMFXSA-N
Summenformel
C23H47N5O18S
Durchschnittliche Molmasse
713,7 g/mol
Monoisotopische Masse
713,26368084

Überblick

Paromomycin sulfate is an aminoglycoside sulfate salt resulting from the treatment of paromomycin with sulfuric acid. A broad-spectrum antibiotic, it is used for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. It has a role as an antiparasitic agent, an anthelminthic drug, an antiprotozoal drug and an antibacterial drug. It is functionally related to a paromomycin.

Namen und Bezeichner

Bevorzugter Name
Paromomycin Sulfate
IUPAC
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric acid
Lokaler Name
Paromomycinsulfate
Englischer Name
PAROMOMYCIN SULFATE
Summenformel
C23H47N5O18S
Molmasse
713.71

Namen und Synonyme

Paromomycin sulfate1263-89-4GabbromicinaGabbroralHumagelAminosidin sulfateAminosidine sulfateAminoxidinFarmiglucinFarminosidinSinosidAminosidine sulphate
Weitere Namen anzeigen
sulfhumatinNEOMYCIN EPAROMOMYCIN SULFATE SALTNeomycin Sulfate EP Impurity EO - 2, 6 - Diamino - 2, 6 - dideoxy - b - L - idopyranosyl - (1,3) - O - b - D - ribofuranosyl - (1,5) - O - [2 - amino - 2 - deoxy - a - D - glucopyranosyl - (1,4) ] - 2 - deoxy - streptamine sulfatefi5853D00868
PargonylHumycin sulfateParomomycin sulphateParamicinaParicina845NU6GJPSGabbromycin1600 Antibiotic

Datenbank-Bezeichner

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
430 Ų
H-Brücken-Donoren
15
H-Brücken-Akzeptoren
23
Frei drehbare Bindungen
9
Schwere Atome
47
Formalladung
0
Komplexität
952

Experimentelle und physikochemische Eigenschaften

Human Drugs · 3 Einträge

Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Amebicides; Anti-Bacterial Agents; Aminoglycosides

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physikochemische Eigenschaften

Schmelzpunkt
145 °C · 145 °C (decomp)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
Löslichkeit
2 O: · H2O: 50 mg/mL store stock solution at 2-8°C. Stable at 37°C for 5 days.
Aggregatzustand
powder
Farbe
White to Off-White
Wasserlöslichkeit
Soluble in water
Merck
14 · 14,7041
BRN
5715182 · 5715182
Stabilität
Hygroscopic
InChIKey
LJRDOKAZOAKLDU-UDXJMMFXSA-N
CAS Datenbank
1263 · 1263-89-4

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 3 Einträge

This chemical does not meet GHS hazard criteria for 93% (53 of 57) of all reports.

Not Classified

Aggregated GHS information provided per 57 reports by companies from 5 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory InformationRegulation (EC) No 1831/2003 (amended)
Hazard Classes and CategoriesNot Classified

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Paromomycin sulfate

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

wgk
2
hs_code
2941901010
RTECS-Nr.
WK2320000
risk_code
23/24/25-36/38-39/23/24/25-61-36/37/38
Toxizität
LD50 in mice (mg/kg): ~15,000 orally; 700 s.c.; 110 i.v. (Di Marco, Bertazzoli)
hazard_code
Xi

Chemie und Industrie

Pharmakologische Informationen

FDA Pharmacological Classification · 2 Einträge

PAROMOMYCIN SULFATE

Antiprotozoal [EPC]

MeSH Pharmacological Classification · 2 Einträge

Substances that are destructive to protozoans.

Substances that inhibit the growth or reproduction of BACTERIA.

Anwendungen · 2 Einträge

BeschreibungParomomycin was found in the culture broth of Streptomyces rimosus forma paromomycinus by Parke Davis & Co. in 1959. In the same year it was found in the culture broth of S. Crestomyceticus by Farmitalia and named amminosidin. Paromomycin is related structurally to neomycin, but it has a hydroxyl group at the 6 position, whereas neomycin has an amino group. Its antibacterial activity is weaker than that of neomycin, but its toxicity is much less. Paromomycin is used by intramuscular injection for therapy of respiratory, urinary, and surgical infections and by oral administration to treat dysentery and salmonellosis.

VerwendenPAROMOMYCIN SULFATE is an aminogycoside antibiotic designed to fight intestinal infections such as cryptosporidiosis, amoebiasis, and leishmaniasis. Its antiprotozoal activity makes it an effecive histomonostatic feed addit ive in turkey poults experimentally infected with Histomonas meleagridis.

Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: An aminoglycoside sulfate salt resulting from the treatment of paromomycin with sulfuric acid. A broad-spectrum antibiotic, it is used for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoa infections. It is also used as a therapeutic against visceral leishmaniasis.

Zugehörige Reaktionen

2
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 1949611
HRID 1949611als Edukt
Reaktionsgleichung von HRID 1949615
HRID 1949615als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
CAS
1263-89-4、7205-49-4
PubChem CID
441375
DTXSID
DTXSID601335979
ChEMBL
CHEMBL2206196
ChEBI
CHEBI:7935
UNII
845NU6GJPS
EC Number
215-031-7、230-575-5
EPA chemische Informationen
Paromomycin sulfate (1263-89-4)
safety_code
26-36/37-45-38-36
Speicherklasse
11 - Combustible Solids